ADINA Act

Hozzl · 2025-06-30T13:09:07Z

Explore the details of House Bill 3821 ADINA Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

6/30/2025, 1:09 PM

Summary of Bill HR 3821

The bill, H.R. 3821 of the 119th Congress, seeks to amend the Federal Food, Drug, and Cosmetic Act to mandate that drug labels intended for human use must specify each ingredient that is directly or indirectly derived from a major food allergen or a gluten-containing grain.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3821

Bill HR 3821 is currently in the status of Bill Introduced since June 6, 2025. Bill HR 3821 was introduced during Congress 119 and was introduced to the House on June 6, 2025. Bill HR 3821's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 6, 2025

Bipartisan Support of Bill HR 3821

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 3821

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 3821

To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.